Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PAAS vs GSK✓SelectedUSD · GSKPAAS vs GSK performance historyLatest closeAs of-0.58%11/13
Stock and ETF performance explorer

PAAS vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+155.9%
GSK return
+107.5%
Excess return
+48.5%
Maximum drawdown
-66.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.6%+0.5%-1.1%-0.8%
7D-8.9%+1.1%-10.1%-9.2%
30D-11.4%+6.3%-17.7%-13.3%
3M-20.4%+1.8%-22.3%-21.2%
6M-40.7%+1.7%-42.3%-41.4%
YTD-26.9%+6.5%-33.5%-29.3%
1Y-3.1%+9.5%-12.6%-7.3%
3Y+199.3%+65.3%+133.9%+132.9%
5Y+48.3%+43.7%+4.6%+21.6%
All+155.9%+107.5%+48.5%+74.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling